Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Feb 24:16:24.
doi: 10.1186/s12874-016-0118-2.

The art and science of study identification: a comparative analysis of two systematic reviews

Affiliations
Comparative Study

The art and science of study identification: a comparative analysis of two systematic reviews

Laura Rosen et al. BMC Med Res Methodol. .

Abstract

Background: Systematic reviews (SRs) form the foundation for guidelines and evidence-based policy in medicine and public health. Although similar systematic reviews may include non-identical sets of studies, and it is recognized that different sets of studies may lead to different conclusions, little work has been published on why SR study cohorts differ.

Methods: We took advantage of concurrent publication of two SRs on the same topic - prevention of child exposure to tobacco smoke - to understand why study cohorts differed in the two reviews. We identified all studies included in just one review, investigated validity of specified reasons for exclusions, and, using database records, explored reasons for study non-identification. We assessed review methods and discordancy, and attempted to assess whether changes in study cohorts would have changed conclusions.

Results: Sixty-one studies were included in the two reviews. Thirty-five studies were present in just one review; of these, twenty were identified and excluded by the parallel review. Omissions were due to: review scope (9 studies, 26%), outcomes of interest not measured (8 studies, 23%), exclusion of reports with inadequate reporting (6 studies, 17%), mixed or unclear reasons (3 studies, 8%), search strategies concerning filters, tagging, and keywords (3 studies, 8%), search strategies regarding sources (PUBMED not searched) (2 studies, 6%); discordant interpretation of same eligibility criteria (2 studies, 6%), and non-identification due to non-specific study topic (2 studies, 6%). Review conclusions differed, but were likely due to differences in synthesis methods, not differences in study cohorts.

Conclusions: The process of study identification for SRs is part art and part science. While some differences are due to differences in review scope, outcomes measured, or reporting practices, others are caused by search methods or discrepancies in reviewer interpretations. Different study cohorts may or may not be a cause of differing SR results. Completeness of SR study cohorts could be enhanced by 1 - independent identification of studies by at least two reviewers, as recommended by recent guidelines, 2 - searching PUBMED with free-text keywords in addition to MEDLINE to identify recent studies, and 3 - Using validated search filters.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Reasons for omission of studies from one of two revews

Similar articles

Cited by

References

    1. Stegenga J. Is meta-analysis the platinum standard of evidence? Stud Hist Philos Biol Biomed Sci. 2011;42(4):497–507. doi: 10.1016/j.shpsc.2011.07.003. - DOI - PubMed
    1. Mulrow CD. Rationale for systematic reviews. BMJ. 1994;309(6954):597–9. doi: 10.1136/bmj.309.6954.597. - DOI - PMC - PubMed
    1. Mullen PD, Ramirez G. The promise and pitfalls of systematic reviews. Annu Rev Public Health. 2006;27:81–102. doi: 10.1146/annurev.publhealth.27.021405.102239. - DOI - PubMed
    1. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896–900. doi: 10.1016/S0140-6736(99)04149-5. - DOI - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12. doi: 10.1016/j.jclinepi.2009.06.005. - DOI - PubMed

Publication types

Substances